Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.02 USD | +33.33% | -.--% | -56.52% |
23/05 | Celadon ships to US; Oxford BioDynamics-Goodbody pact | AN |
20/05 | IQ-AI subsidiary gets second FDA rare paediatric disease designation | AN |
Sales 2022 | 5L 7L 5.69Cr | Sales 2023 | 6L 8L 6.48Cr | Capitalization | 89.62L 1.14Cr 95Cr |
---|---|---|---|---|---|
Net income 2022 | - 0 0 | Net income 2023 | - 0 0 | EV / Sales 2022 | 5.75 x |
Net cash position 2022 | 3L 3L 2.68Cr | Net cash position 2023 | 1L 2L 1.47Cr | EV / Sales 2023 | 14.5 x |
P/E ratio 2022 |
-6.52
x | P/E ratio 2023 |
-13.8
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 61.72% |
1 day | +33.33% | ||
1 month | +17.65% | ||
3 months | +3.09% | ||
6 months | -56.52% | ||
Current year | -56.52% |
Managers | Title | Age | Since |
---|---|---|---|
Trevor Brown
CEO | Chief Executive Officer | 78 | 13/15/13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Trevor Brown
CEO | Chief Executive Officer | 78 | 13/15/13 |
Vinod Kaushal
BRD | Director/Board Member | 60 | 20/17/20 |
Director/Board Member | - | 18/19/18 |
1st Jan change | Capi. | |
---|---|---|
-24.16% | 776.06Cr | |
+68.65% | 433.23Cr | |
-2.98% | 264.08Cr | |
+2.72% | 263.49Cr | |
-46.17% | 216.15Cr | |
-15.27% | 175.09Cr | |
-22.12% | 146.25Cr | |
+13.62% | 117.04Cr | |
-43.81% | 114.45Cr |
- Stock Market
- Equities
- IQAI Stock
- IQAIF Stock